MAYEALIE ADAMS — Lobbyist Profile | Poliscope

MAYEALIE ADAMS

Filings

Clients

Firms

Years active

2022–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
DANAHER CORPORATION	17	2022–2026

Lobbying firms

Firm	Filings	Years
DANAHER CORPORATION	17	2022–2026

Bills explicitly cited in this lobbyist’s assigned issues (8)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 7085

To amend the Public Works and Economic Development Act of 1965 to authorize the Secretary of Commerce to make predevelopment grants, and for other purposes.

Client: DANAHER CORPORATION · Firm: DANAHER CORPORATION

Open original LDA filing ↗

Cited source text

Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments Discussions regarding Executive Order regarding outbound investments Discussions regarding S.3558/H.R.7085, the BIOSECURE Act

S. 1854

National Critical Capabilities Defense Act of 2021

Client: DANAHER CORPORATION · Firm: DANAHER CORPORATION

Open original LDA filing ↗

Original LDA source filings (17)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

DANAHER CORPORATION via DANAHER CORPORATION

2026 · third_quarter · Q3

Firm income: —Client expense: $190,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Issues related to biotechnology, cell and gene therapy

TAR

Tariff (miscellaneous tariff bills)

General issues related to tariffs

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

DANAHER CORPORATION

Source: Senate LDA

Show 13 more original filings

DANAHER CORPORATION via DANAHER CORPORATION

2025 · third_quarter · Q3

Firm income: —Client expense: $270,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

Issues related to genomic medicines Issues related to biotechnology, cell and gene therapy

TAR

Tariff (miscellaneous tariff bills)

General issues related to tariffs

TRD

Trade (domestic/foreign)

Discussions regarding export controls

Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

DANAHER CORPORATION via DANAHER CORPORATION

2025 · second_quarter · Q2

Firm income: —Client expense: $220,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Issues related to genomic medicines Issues related to biotechnology, cell and gene therapy

TAR

Tariff (miscellaneous tariff bills)

General issues related to tariffs

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office

DANAHER CORPORATION via DANAHER CORPORATION

2025 · first_quarter · Q1

Firm income: —Client expense: $230,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

Issues related to genomic medicines Issues related to biotechnology, cell and gene therapy

TAR

Tariff (miscellaneous tariff bills)

General issues related to tariffs

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office

DANAHER CORPORATION via DANAHER CORPORATION

2024 · fourth_quarter · Q4

Firm income: —Client expense: $180,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

LBR

Labor Issues/Antitrust/Workplace

General issues related to antitrust laws

TAR

Tariff (miscellaneous tariff bills)

General issues related to permanent normal trade relations

HCR

Health Issues

Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081 Issues related to genomic medicines Issues related to biotechnology, cell and gene therapy

Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

DANAHER CORPORATION via DANAHER CORPORATION

2024 · third_quarter · Q3

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

DANAHER CORPORATION via DANAHER CORPORATION

2024 · second_quarter · Q2

Firm income: —Client expense: $190,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

DANAHER CORPORATION via DANAHER CORPORATION

2024 · first_quarter · Q1

Firm income: —Client expense: $180,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPI

Computer Industry

Discussions regarding the White House Executive Order on Artificial Intelligence (AI)

HCR

Health Issues

Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081

TRD

Trade (domestic/foreign)

Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments Discussions regarding Executive Order regarding outbound investments Discussions regarding S.3558/H.R.7085, the BIOSECURE Act

Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office

DANAHER CORPORATION via DANAHER CORPORATION

2023 · fourth_quarter · Q4

Firm income: —Client expense: $200,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPI

Computer Industry

CHIPS Act Implementation

TRD

Trade (domestic/foreign)

Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments Discussions regarding Executive Order regarding outbound investments

HCR

Health Issues

Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081

Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office

DANAHER CORPORATION via DANAHER CORPORATION

2023 · third_quarter · Q3

Firm income: —Client expense: $200,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPI

Computer Industry

CHIPS Act Implementation

HCR

Health Issues

Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081

TRD

Trade (domestic/foreign)

Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments Discussions regarding Executive Order regarding outbound investments

Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office

DANAHER CORPORATION via DANAHER CORPORATION

2023 · second_quarter · Q2

Firm income: —Client expense: $250,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081 Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) Terminations of Public Health Emergency (PHE)

TRD

Trade (domestic/foreign)

Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments Discussions regarding Executive Order regarding outbound investments

CPI

Computer Industry

CHIPS Act Implementation

DANAHER CORPORATION via DANAHER CORPORATION

2023 · first_quarter · Q1

Firm income: —Client expense: $200,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

CPI

Computer Industry

CHIPS Act Implementation

HCR

Health Issues

Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081

LBR

Labor Issues/Antitrust/Workplace

Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) Terminations of Public Health Emergency (PHE)

TRD

DANAHER CORPORATION via DANAHER CORPORATION

2022 · fourth_quarter · Q4

Firm income: —Client expense: $100,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

Implementation of corporate minimum tax

HCR

Health Issues

Discussions regarding National Biotechnology and Biomanufacturing Initiative - Executive Order 14081

TRD

Trade (domestic/foreign)

Discussions regarding S.1854 - National Critical Capabilities Defense Act of 2021 provisions regarding outbound investments Discussions regarding Executive Order regarding outbound investments

Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office

DANAHER CORPORATION via DANAHER CORPORATION

2022 · fourth_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

Domestic and international tax policy including corporate minimum tax issues and Global Intangible Low Tax Income (GILTI). Tariffs, export controls, outbound investments. Biotechnology and biomanufacturing.

HCR

Health Issues

TAX

Taxation/Internal Revenue Code